Connect with us

Events

2nd Cannabis Clinical Trials Congress takes place in London in February

Published

em

Listen to this article

After the first edition, in 2019, the 2nd International Congress of Clinical Trials with Cannabis will take place in London, on the 15th and 16th of February, at the Hilton London Canary Wharf Hotel, in South Quay Square. Organized by BioEvents and endorsed by Medical Cannabis Clinicians Society (Medical Cannabis Clinicians Society – MCCS) the event has a panel of renowned speakers in the area of ​​medical cannabis and still has the abstract and poster submission until next Monday, January 9th.

The event aims to inform about the latest evidence and concepts related to cannabinoid therapy and will help prescribers to implement best practices based on the clinical implications of current research and expert opinion. It will also serve as a platform for the exchange of ideas and practices in cannabinoid medicine. The Cannareporter is media partner of this Congress.

Program and Speakers
The main speakers at the SCHEDULE from CT-Cann2023 are international experts to discuss ways to improve research strategies, new discoveries, practical dilemmas and future paths in a rapidly evolving sector. Aimed not only at MCCS members but also at anyone who wants to learn more about cannabis treatments, the conference will cover basic and clinical methodologies, regulatory and legal issues, pharmacological considerations and technological advances, emphasizing the practical implications for patients, researchers, prescribers and industry.

Among the confirmed speakers are:

  • Mike Barnes, Medical Cannabis Clinicians Society, UK;
  • Staci Gruber, McLean Hospital Cognitive and Clinical Neuroimaging Core and Marijuana Investigations for Neuroscientific Discovery (MIND), Dept. of Psychiatry at Harvard Medical School, USA;
  • Arun Bhaskar, Imperial College Healthcare NHS Trust, UK;
  • Silviu Brill, Institute for Pain Medicine, Tel Aviv Medical Center, Israel;
  • Eliad Davidson, Pain Relief Unit, Hadassah Hebrew University Medical Center, Israel;
  • David Finn, University of Galway, Ireland;
  • Dedi Meiri – Congress Co-Chair, Faculty of Biology, Technion Israel Institute of Technology, Israel;
  • Haggai Sharon – Co-Chair of Congress, Sagol Brain Institute and Institute of Pain Medicine Tel Aviv Medical Center and Sackler Faculty of Medicine, Israel. President of the Israel Pain Association

Last days to submit Abstracts
Congress has been warning of the submission of abstract originals, oral presentation and/or Posters, whose deadline ends next Monday, January 9th, 2023. Topics may include:

  • Study of phytocannabinoids – varieties, chemovars, entourage and molecules
  • Pharmacokinetics and pharmacodynamics of cannabinoids
  • Clinical therapy with cannabinoids in various medical specialties; Pain, Gastroenterology, Palliative Care, Psychiatry and Neurology
  • New designs for cannabis clinical trials (including pragmatic en=1 trials)
  • Clinical Records
  • Observational/epidemiological studies: findings, interpretations, plans
  • Phase 2/3/4 findings and study projects (including special populations)
  • Meta and composite analyzes: findings and methodology
  • Regulatory, licensing and development program issues and plans
  • Best conduct of cannabinoid testing including GCP and onsite training
  • Assessment of safety and adverse effects of cannabinoid drugs
  • Clinical trials with psychedelics, theory and practice

Congressional registration costs between £300 and £700 and can be done on this link.

 

________________________________________________________________________________________

 

If you like CannaReporter, please consider supporting independent journalism by making a donation on our Patreon account.

From just €3/month!

________________________________________________________________________________________

[Disclaimer: Please note that this text was originally written in Portuguese and is translated into English and other languages ​​using an automatic translator. Some words may differ from the original and typos or errors may occur in other languages.]
Click here to comment

Leave a comment

Your email address will not be published. Required fields are marked *

Advertising


Watch the Documentary "Patients"

Documentary Patients Laura Ramos help us grow

Mais recentes

Events2 days ago

EVO NXT: Next Generation Products Festival returns to Malaga and Cannabis will be in the spotlight

The 2nd edition of the Business Festival for Next Generation Products, EVO NXT, returns to Malaga this...

International7 days ago

It's official: Germany is the third country in Europe to legalize the recreational use of cannabis

The Bundesrat approved today, Friday, the bill to regulate the use of cannabis for recreational purposes in the country....

BusinessCann1 weeks ago

Germany: Cannabis legalization on the brink? Bundesrat votes on bill tomorrow

Most media outlets announced the legalization of cannabis in Germany as a fait accompli, but...

National1 weeks ago

Portugal: Medicinal cannabis on Madeira Island with autonomous licensing process from the mainland

The Autonomous Region of Madeira is taking over the licensing of activities related to medicinal cannabis in the archipelago, in accordance...

International1 weeks ago

Norway: Activists send 200g of cannabis to the Prime Minister and other politicians by post

Norwegian activists from the Alliance for Human Rights-Oriented Drug Policy (AROD) sent 10 letters with 200...

Events1 weeks ago

Spain: Exponential growth of Spannabis dictates expansion to Bilbao in September

The 20th edition of Spannabis 2024, one of the oldest and largest cannabis fairs in the world, ended yesterday with...

International1 weeks ago

Morocco enters the cannabis race with the first legal cannabis harvest

The year 2023 will go down in Morocco's history as the year in which the first legal harvest of...

Hemp2 weeks ago

USA: USDA announces investment of 10 million in hemp research

The United States Department of Agriculture (USDA) recently released the “Hemp Research Needs Map” and announced a...

Interviews2 weeks ago

Jacqueline Poitras: “Doctors are painfully ignorant when it comes to cannabinoids and their effects on the human body”

Founder of 'MAMAKA- Mothers for Cannabis', an association for medical cannabis patients in Greece, Jacqueline Poitras has been a...

International2 weeks ago

Understanding the UN System & Our Role at CND67 - Midterm Review

The United Nations, in Vienna, hosts annual sessions of the Commission on Narcotic Drugs (CND). These sessions provide opportunities for organizations without...